Loading ...
Rapid Fire Part 2 with Medscape Faculty!
Happy Summer, MedscapeLive! Dermatology Newsletter Readers! We hope you are having an amazing, healthy summer season. As we all know more than any other clinicians in healthcare, summer is the most critical season for sun protection, and in this issue, Medscape’s PDE faculty candidly share their thoughts and opinions on a variety of current topics, treatments, and debates in the PDE space and in clinical and aesthetic dermatology more generally. Read on to see what they say when the microphone is off!
Check out this month’s Derm Resource section, with articles from JAMA Dermatology, Dermatology News, Cutis, NEJM and more. Thank you to these thought leaders featured in this issue for sharing their perspectives. Please contact me at colleen@cmhadvisors.com with comments or suggestions. Thanks for reading! —Colleen Hutchinson
Need CME? We’ve got you covered!
Skin of Color Update • New York Hilton Midtown • New York, NY, September 13-15, 2024
- One-of-a-kind, 2-day event covering the latest updates on diagnostic, therapeutic, and cosmetic treatment best practices for dermatologic conditions in populations with skin of color.
- Goals: 1- To educate dermatology clinicians and trainees to best diagnose and treat dermatologic disorders in populations with skin of color, including those that disproportionately affect higher skin phototypes. 2- To educate clinicians and trainees to best treat the aesthetic needs of patients with skin of color.
- To register, click here!
25th Annual Las Vegas Dermatology Seminar • Fontainebleau Las Vegas • Las Vegas, NV, September 19-21, 2024
- One-of-a-kind, three day meeting with renowned faculty and informative presentations on atopic dermatitis, psoriasis, acne, rosacea, and more.
- Final day dedicated to cutaneous malignancies, including two unique presentations and a dermoscopy course you won’t want to miss.
- To register, click here!
Rapid Fire Part 2 with Our PDE Thought Leaders…
Issue in dermatology that needs more attention to solutions:
Dr. Grimes: While we have better treatments for melasma, relapses remain universal! We are still in dire need of therapies that provide long-term remission. We need new therapies for vitiligo that expedite repigmentation.
Dr. Passeron: PIH. Resistant areas (wrist, fingers, feet) in vitiligo as they are not responding to any of the immune-based new therapeutic options.
Dr. Harris: Focus on pigmentary disease for drug development.
Dr. Taylor: Pigmentation.
Most reliable tool in my clinical arsenal:
Dr. Grimes: I am embarrassed to say that it is still hydroquinone. I cannot survive without this 70-year-old treatment.
Dr. Soon: Hydroquinone.
Dr. Passeron: Wood’s lamp.
Dr. Harris: nbUVB
Dr. Hamzavi: Vitiligo surgery.
Dr. Taylor: Hydroquinone.
Lasers and energy-based devices for pigmentary disorders:
Dr. Passeron: Very effective for some hyperpigmentary lesions. Still disappointing for melasma.
Dr. Taylor: Evolving.
Most easily avoidable complication I see:
Dr. Grimes: Post-inflammatory hyperpigmentation.
Dr. Soon: Post-inflammatory hyperpigmentation.
Dr. Thierry Passeron: Complications due to the long-term use of hydroquinone as we now have as-effective cosmetic depigmenting agents.
Dr. Hamzavi: Progression of disease because treatment was not initiated early enough.
Dr. Taylor: Perform test spots before laser treatments on soc patients to avoid PIH.
Best part of caring for my patients:
Dr. Soon: Improving their quality of life.
Dr. Passeron: Patients with pigmentary disorders often suffer a lot and when we improve their condition, it is great to see how it can improve their life!
Dr. Harris: Providing the education and treatment they’ve been seeking for a long time! They need our focus and dedication, and are so appreciative when we are there for them!
Dr. Taylor: The ability to make a difference!!
Dermatology Resource Section:
Cutis Commentary: Benzoyl Peroxide, Benzene, and Lots of Unanswered Questions: Where Are We Now?
JAMA Dermatology—Viewpoint: Antihypertensive Medications and Eczematous Dermatitis in Older Adults
NEJM Perspective: My First Patient
Dermatology News Study Finds Differences in Side Effect Profiles With Two Oral Psoriasis Therapies
Cutis The State of Skin of Color Centers in the United States: A Cross-Sectional Survey Study
Loading ...